Stay updated on Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from **v3.5.0** to **v3.5.3**, reflecting a change in the ClinicalTrials.gov front-end release without altering the displayed study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:26:39.000Z thumbnail image
  3. Check
    24 days ago
    No Change Detected
  4. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now shown, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T19:02:32.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T07:45:05.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2 in the footer, replacing v3.4.1; no study data or functionality were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T16:34:11.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no core study content, eligibility criteria, locations, or results appear to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:14:40.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    UI updates add Show glossary and Hide glossary controls and minor metadata label changes (e.g., Last Update Submitted that Met QC Criteria and Revision: v3.4.0), which do not affect the study content, eligibility, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-23T05:21:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.